Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer

Recruiting now

Conditions studied: Rectal Cancer

In brief

Many patients with rectal cancer were not candidates for surgical resection because advanced age, comorbidities, or multiple synchronous metastases. In this scenario only comfort measures or different palliative radiotherapy regimens are applied, from single doses to treatments lasting several weeks. The aim of this prospective study is to describe the preliminary results of our protocol of hypofractionated palliative radiotherapy in patients with non-operable rectal cancer.

Key facts

Study ID

NCT03853733

Run by

Consorci Sanitari de Terrassa

People needed

50

Starts

2016-10-01

Expected to finish

2027-03-01

Last updated by the study team

2026-03-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with rectal or sigmoidal cancer who were not candidates for surgical resection because advanced age, comorbidities, or multiple synchronous metastases at the time of diagnosis
• Patients with = or > 18 years old
• Patients treated with a radiotherapy dose of 39Gy in 13 fractions of 3 Gy

You may not qualify if…

• Patients with a non rectum or sigma colo-rectal cancer.
• Patients with <18 years old.
• Patients treated with concurrent chemotherapy
• Patients candidates for surgical resection after radiotherapy

Where it is running

• Consorci Sanitari de Terrassa — Terrassa, Catalonia, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.